复方异丙托溴铵联合布地奈德混悬液治疗支气管哮喘疗效
CSTR:
作者:
作者单位:

(江门市五邑中医院恩平分院,广东 恩平 529400)

作者简介:

邵景天,男,主治医师,主要研究方向是呼吸内科学。

通讯作者:

中图分类号:

R 562.2+ 5

基金项目:


Efficacy of Compound Ipratropium Bromide Combined with Budesonide Suspension in Treating Bronchial Asthma
Author:
Affiliation:

(Enping Branch of Jiangmen Wuyi Traditional Chinese Medicine Hospital, Guangdong Enping 529400)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    〔摘 要〕 目的:探索吸入用复方异丙托溴铵溶液联合吸入用布地奈德混悬液对支气管哮喘的治疗效果。方法:选取江 门市五邑中医院恩平分院 2019 年 5 月至 2020 年 5 月期间收治的 60 例支气管哮喘患者,随机分为对照组与观察组,各 30 例。 对照组予吸入用布地奈德混悬液雾化吸入治疗,观察组在对照组的基础上联合吸入用复方异丙托溴铵溶液雾化吸入治疗。 观察记录两组患者治疗 7 d 后的临床疗效,临床症状、体征(如咳嗽、气喘、肺部哮鸣音)的改善时间以及连续治疗 14 d 后 的肺功能改善情况,并记录研究期间的不良反应事件。结果:观察组患者治疗总有效率为 93.33 %,高于对照组的 70.00 %, 差异具有统计学意义(P < 0.05)。观察组患者的咳嗽、气喘、肺部哮鸣音改善时间短于对照组,差异具有统计学意义 (P < 0.05)。治疗前两组患者的第 1 秒用力呼气容积(FEV1)、用力肺活量(FVC)、第 1 秒用力呼气容积占用力肺活 量比值(FEV1/FVC)水平比较,差异无统计学意义(P > 0.05);治疗 14 d 后,两组患者的 FEV1、FVC、FEV1/FVC 水 平均较治疗前改善,且观察组的 FEV1、FVC、FEV1/FVC 均优于对照组,差异具有统计学意义(P < 0.05)。结论:吸入 用复方异丙托溴铵溶液联合吸入用布地奈德混悬液治疗支气管哮喘可有效改善患者咳嗽、气喘症状,改善肺部哮鸣音的体征, 显著改善肺功能。

    Abstract:

    〔Abstract〕 Objective To explore the therapeutic efficacy of inhaled compound ipratropium bromide solution combined with inhaled budesonide suspension in treating bronchial asthma. Methods 60 patients with bronchial asthma treated in Enping Branch of Jiangmen Wuyi Traditional Chinese Medicine Hospital from May 2019 to May 2020 were selected and divided randomly into the control group and the observation group, each with 30 cases. The control group was treated with budesonide suspension nebulized inhalation, and the observation group was treated with inhalation of compound ipratropium bromide solution on the basis of the control group. The clinical efficacy of the two groups of patients after 7 days of treatment, the improvement time of clinical symptoms, signs (such as cough, wheezing, and lung wheezing), and the improvement of lung function after 14 days of continuous treatment and record the adverse events during the study period. Results The total effective rate of observation group was 95.00 %, which was higher than 77.50 % of control group, the difference was statistically significant (P < 0.05). The improvement time of cough, asthma and lung wheezing of observation group was shorter than that of control group, the difference were statistically significant (P < 0.05). Before treatment, there was no significant difference in the levels of forced expiratory volume (FEV1), forced vital capacity (FVC) and the ratio of forced expiratory volume to forced vital capacity (FEV1/FVC) between the two groups (P > 0.05). After 14 days of treatment, the levels of FEV1, FVC and FEV1/FVC of the two groups were improved compared with those before treatment, and the FEV1, FVC and FEV1/FVC of observation group were better than those of control group, the difference had statistical significance (P < 0.05). Conclusion Inhaled compound ipratropium bromide solution combined with inhaled budesonide suspension has a significant efficacy in treating bronchial asthma. It can effectively improve the symptoms of cough, asthma and the signs of lung wheezing as well as the lung function.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-07-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-04-18
  • 出版日期:
文章二维码
特别声明

近期有不法分子冒充我刊名义给作者打电话或发邮件,编造各种理由要求添加微信或QQ、伪造复制我刊编辑部公章发放假冒录用通知书等等各种方式试图骗取作者钱财。为强化编辑部工作规范,加强单位公章管理,维护作者的正当权益和财产利益, 我刊在此郑重声明:(1)编辑部与作者沟通方式为电话和邮件,在本刊唯一官方网站(http:/szzxyjhzz.szrch.com)“联系我们”下拉菜单,或者网站最下端信息栏可以查询),绝对不会要求作者添加微信或QQ。 (2)自2025年2月1日起,注销废除“深圳中西医结合杂志编辑部”电子公章;我刊稿件录用通知调整为加盖编辑部实体公章的纸质文件或其扫描件,录用稿件仅收取合理版面制作费和审稿费,收款单位为“深圳市第二人民医院”对公账户,其他加盖电子公章或涉及私人账户者均为伪造假冒。望广大作者提高警惕,谨防上当受骗。 《深圳中西医结合杂志》编辑部

关闭